Home
ADAP
ADAP News

Latest Adaptimmune Therapeutics plc (ADAP) News on July 26, 2024

Why Are Hedge Funds Bullish on Adaptimmune Therapeutics plc (ADAP) Now?

Insider Monkey

2 days ago

Why Are Hedge Funds Bullish on Adaptimmune Therapeutics plc (ADAP) Now?

5 FDA decisions to watch in the third quarter

BioPharma Dive

24 days ago

5 FDA decisions to watch in the third quarter

Zacks Small Cap Research

24 days ago

Fireside Chat with Adrian Rawcliffe, Chief Executive Officer of Adaptimmune

ADAP: Initiating Coverage of Adaptimmune, a Leading T-Cell Therapy Company

Zacks Small Cap Research

a month ago

ADAP: Initiating Coverage of Adaptimmune, a Leading T-Cell Therapy Company

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

Yahoo Finance Video

2 months ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

GlobeNewswire

2 months ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit

Reuters

2 months ago

California seeks company profits in Big Oil climate lawsuit

USA TODAY

2 months ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

GlobeNewswire

2 months ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Business Wire

2 months ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Business Wire

2 months ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

GlobeNewswire

2 months ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Lotto 6/49 - $64 million up for grabs in the next draw!

CNW Group

2 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

2 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

2 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

2 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

2 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

2 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

2 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

2 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Adaptimmune to Present Data from Planned Interim Analysis of Pivotal IGNYTE-ESO Trial with Lete-cel at ASCO; Data Continue to Support further Development of Sarcoma Franchise

Newsfile

2 months ago

Adaptimmune to Present Data from Planned Interim Analysis of Pivotal IGNYTE-ESO Trial with Lete-cel at ASCO; Data Continue to Support further Development of Sarcoma Franchise

MT Newswires

2 months ago

Galapagos, Adaptimmune Therapeutics Team Up to Evaluate Head and Neck Cancer Drug

Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune's TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future Solid Tumor Indications

Newsfile

2 months ago

Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune's TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future Solid Tumor Indications

MT Newswires

2 months ago

Scotiabank Starts Adaptimmune Therapeutics With Sector Outperform Rating

MT Newswires

2 months ago

Mizuho Slashes Price Target on Adaptimmune Therapeutics to $3 From $9, Keeps Buy Rating

MT Newswires

2 months ago

Adaptimmune Therapeutics Enters Into $125 Million Term Loan Facility With Hercules Capital

Adaptimmune Reports Q1 2024 Financial and Business Updates

Newsfile

2 months ago

Adaptimmune Reports Q1 2024 Financial and Business Updates

Adaptimmune Secures up to $125 Million Debt Financing with Hercules Capital

Newsfile

2 months ago

Adaptimmune Secures up to $125 Million Debt Financing with Hercules Capital

Adaptimmune to Report Q1 2024 Financial and Business Updates on Wednesday, May 15, 2024

Newsfile

3 months ago

Adaptimmune to Report Q1 2024 Financial and Business Updates on Wednesday, May 15, 2024

Adaptimmune (ADAP) Down on End of Collaboration With Roche

Zacks

3 months ago

Adaptimmune (ADAP) Down on End of Collaboration With Roche

Strategic Collaboration between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies Terminated

Newsfile

3 months ago

Strategic Collaboration between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies Terminated

Roche, Adaptimmune part ways on cell therapy research

BioPharma Dive

3 months ago

Roche, Adaptimmune part ways on cell therapy research

Results of Adaptimmune's SPEARHEAD-1 Trial with Afami-cel in Advanced Sarcomas Published in the Lancet

Newsfile

4 months ago

Results of Adaptimmune's SPEARHEAD-1 Trial with Afami-cel in Advanced Sarcomas Published in the Lancet

Adaptimmune Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

5 months ago

Adaptimmune Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Adaptimmune Therapeutics PLC Reports Q4 and Full Year 2023 Financial Results

GuruFocus.com

5 months ago

Adaptimmune Therapeutics PLC Reports Q4 and Full Year 2023 Financial Results

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q4 2023 Earnings Call Transcript

Insider Monkey

5 months ago

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q4 2023 Earnings Call Transcript

Adaptimmune Reports Q4/Full Year 2023 Financial Results and Business Updates

Newsfile

5 months ago

Adaptimmune Reports Q4/Full Year 2023 Financial Results and Business Updates

Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise

Newsfile

5 months ago

Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise

Adaptimmune to Report Q4 and Full Year 2023 Financial and Business Updates on Wednesday, March 6, 2024

Newsfile

5 months ago

Adaptimmune to Report Q4 and Full Year 2023 Financial and Business Updates on Wednesday, March 6, 2024

15 Top Performing European Stocks So Far in 2024

Insider Monkey

5 months ago

15 Top Performing European Stocks So Far in 2024

Adaptimmune Therapeutics PLC (ADAP) Stock Moves -1.24%: What You Should Know

Zacks

5 months ago

Adaptimmune Therapeutics PLC (ADAP) Stock Moves -1.24%: What You Should Know

Adaptimmune Announces U.S. FDA Acceptance of Biologics License Application for Afami-cel for the Treatment of Advanced Synovial Sarcoma with Priority Review

Newsfile

6 months ago

Adaptimmune Announces U.S. FDA Acceptance of Biologics License Application for Afami-cel for the Treatment of Advanced Synovial Sarcoma with Priority Review

Baillie Gifford Increases Stake in Adaptimmune Therapeutics PLC

GuruFocus.com

6 months ago

Baillie Gifford Increases Stake in Adaptimmune Therapeutics PLC

With 30% stake, 1stdibs.Com, Inc. (NASDAQ:DIBS) seems to have captured institutional investors' interest

Simply Wall St.

6 months ago

With 30% stake, 1stdibs.Com, Inc. (NASDAQ:DIBS) seems to have captured institutional investors' interest

First Mid Bancshares Full Year 2023 Earnings: EPS Misses Expectations

Simply Wall St.

6 months ago

First Mid Bancshares Full Year 2023 Earnings: EPS Misses Expectations

RBB Bancorp (NASDAQ:RBB) Q4 2023 Earnings Call Transcript

Insider Monkey

6 months ago

RBB Bancorp (NASDAQ:RBB) Q4 2023 Earnings Call Transcript

Alimera Sciences (NASDAQ:ALIM) shareholders have endured a 69% loss from investing in the stock five years ago

Simply Wall St.

6 months ago

Alimera Sciences (NASDAQ:ALIM) shareholders have endured a 69% loss from investing in the stock five years ago

Why WW International Stock Bounced 6% Higher Today

Motley Fool

6 months ago

Why WW International Stock Bounced 6% Higher Today

Cohen & Steers Announces Retirement of William Scapell, Head of Fixed Income and Preferred Securities, Effective August 1, 2024

PR Newswire

6 months ago

Cohen & Steers Announces Retirement of William Scapell, Head of Fixed Income and Preferred Securities, Effective August 1, 2024

Dakota Gold Intersects Multiple High-Grade Zones with Visible Gold Mineralization, Including 4.871 oz/ton Au over 3.4 ft (167.0 g/t over 1.0 m), 1200 feet South of the JB Gold Zone on Its Maitland Gold Project

Newsfile

6 months ago

Dakota Gold Intersects Multiple High-Grade Zones with Visible Gold Mineralization, Including 4.871 oz/ton Au over 3.4 ft (167.0 g/t over 1.0 m), 1200 feet South of the JB Gold Zone on Its Maitland Gold Project

Adaptimmune Therapeutics (NASDAQ:ADAP shareholders incur further losses as stock declines 22% this week, taking three-year losses to 88%

Simply Wall St.

6 months ago

Adaptimmune Therapeutics (NASDAQ:ADAP shareholders incur further losses as stock declines 22% this week, taking three-year losses to 88%

Adaptimmune (ADAP) Surges More Than 80% in a Month: Here's Why

Zacks

6 months ago

Adaptimmune (ADAP) Surges More Than 80% in a Month: Here's Why

Insider Sell: Solid Power Inc CTO Joshua Buettner-garrett Sells 187,500 Shares

GuruFocus.com

6 months ago

Insider Sell: Solid Power Inc CTO Joshua Buettner-garrett Sells 187,500 Shares

Smartfren Telecom and Aviat Establish Strategic Collaboration in Indonesia

PR Newswire

7 months ago

Smartfren Telecom and Aviat Establish Strategic Collaboration in Indonesia

Precigen Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare Conference

PR Newswire

7 months ago

Precigen Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare Conference

The Zacks Analyst Blog Highlights VirTra, REX American Resources, Universal Stainless & Alloy Products, Runway Growth Finance and Carrols Restaurant Group

Zacks

7 months ago

The Zacks Analyst Blog Highlights VirTra, REX American Resources, Universal Stainless & Alloy Products, Runway Growth Finance and Carrols Restaurant Group

Adaptimmune Projects Sarcoma Franchise to Deliver US Peak Year Sales up to $400 Million - Presentation at JP Morgan Healthcare Conference

Newsfile

7 months ago

Adaptimmune Projects Sarcoma Franchise to Deliver US Peak Year Sales up to $400 Million - Presentation at JP Morgan Healthcare Conference

Camden National Corporation to Announce Quarter and Year Ended December 31, 2023 Financial Results on January 30, 2024

PR Newswire

7 months ago

Camden National Corporation to Announce Quarter and Year Ended December 31, 2023 Financial Results on January 30, 2024

Red River Bancshares (NASDAQ:RRBI) Ticks All The Boxes When It Comes To Earnings Growth

Simply Wall St.

7 months ago

Red River Bancshares (NASDAQ:RRBI) Ticks All The Boxes When It Comes To Earnings Growth

Here's Why We Think Tootsie Roll Industries (NYSE:TR) Might Deserve Your Attention Today

Simply Wall St.

7 months ago

Here's Why We Think Tootsie Roll Industries (NYSE:TR) Might Deserve Your Attention Today

NaaS Technology Inc. Announces Amendment of Share Incentive Plan

PR Newswire

7 months ago

NaaS Technology Inc. Announces Amendment of Share Incentive Plan

Will Gambling.com (GAMB) be a Strong Long-Term Compounder?

Insider Monkey

7 months ago

Will Gambling.com (GAMB) be a Strong Long-Term Compounder?

Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution

PR Newswire

7 months ago

Calamos Investments Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW, CCD and CPZ) Announce Monthly Distributions and Required Notifications of Sources of Distribution

Investors Don't See Light At End Of American Well Corporation's (NYSE:AMWL) Tunnel

Simply Wall St.

7 months ago

Investors Don't See Light At End Of American Well Corporation's (NYSE:AMWL) Tunnel

Positive week for Adaptimmune Therapeutics plc (NASDAQ:ADAP) institutional investors who lost 68% over the past year

Simply Wall St.

8 months ago

Positive week for Adaptimmune Therapeutics plc (NASDAQ:ADAP) institutional investors who lost 68% over the past year

Adaptimmune Completes Submission of Rolling Biologics License Application (BLA) to U.S. FDA for Afami-cel for the Treatment of Advanced Synovial Sarcoma

Newsfile

8 months ago

Adaptimmune Completes Submission of Rolling Biologics License Application (BLA) to U.S. FDA for Afami-cel for the Treatment of Advanced Synovial Sarcoma

Exelixis (EXEL) Collaborates With Arcus for Kidney Cancer Study

Zacks

8 months ago

Exelixis (EXEL) Collaborates With Arcus for Kidney Cancer Study

Adaptimmune (ADAP) Rises as GSK Transfers T-Cell Therapy IND

Zacks

8 months ago

Adaptimmune (ADAP) Rises as GSK Transfers T-Cell Therapy IND

3 Infrastructure Stocks to Buy as They Build the Future

InvestorPlace

8 months ago

3 Infrastructure Stocks to Buy as They Build the Future

Tech’s Best Kept Secrets: 7 Under-the-Radar Stocks to Watch

InvestorPlace

8 months ago

Tech’s Best Kept Secrets: 7 Under-the-Radar Stocks to Watch

Associated Press Finance

8 months ago

Yirendai: Q3 Earnings Snapshot

PR Newswire

8 months ago

Yiren Digital Reports Third Quarter 2023 Financial Results

Youdao, Inc. (NYSE:DAO) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

Youdao, Inc. (NYSE:DAO) Q3 2023 Earnings Call Transcript

PR Newswire

8 months ago

Yiren Digital to Report Third Quarter 2023 Financial Results on November 21, 2023

Yiren Digital (NYSE:YRD) investors are sitting on a loss of 86% if they invested five years ago

Simply Wall St.

8 months ago

Yiren Digital (NYSE:YRD) investors are sitting on a loss of 86% if they invested five years ago

Thomson Reuters StreetEvents

9 months ago

Q3 2023 Priority Technology Holdings Inc Earnings Call

Priority Technology Holdings Inc (PRTH) Reports Robust Revenue and EBITDA Growth in Q3 2023

GuruFocus.com

9 months ago

Priority Technology Holdings Inc (PRTH) Reports Robust Revenue and EBITDA Growth in Q3 2023

Thomson Reuters StreetEvents

9 months ago

Q3 2023 Kimbell Royalty Partners LP Earnings Call

GuruFocus.com

9 months ago

Kimbell Royalty Partners LP (KRP) Announces Record Q3 2023 Results with Net Income of $18.5 Million

Kimbell Royalty Partners Announces Record Third Quarter 2023 Results

PR Newswire

9 months ago

Kimbell Royalty Partners Announces Record Third Quarter 2023 Results

Associated Press Finance

9 months ago

Faro Technologies: Q3 Earnings Snapshot

FARO Announces Third Quarter Financial Results

PR Newswire

9 months ago

FARO Announces Third Quarter Financial Results

Companhia Brasileira de Distribuição (NYSE:CBD) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Companhia Brasileira de Distribuição (NYSE:CBD) Q3 2023 Earnings Call Transcript

Share on Social Networks: